Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
The current Bristol-Myers Squibb(BMY) stock price is $54.37, with a market capitalization of 110.33B. The stock trades at a price-to-earnings (P/E) ratio of 18.33 and offers a dividend yield of 4.6%.
During the trading session on 2025-12-16, Bristol-Myers Squibb(BMY) shares reached a daily high of $54.72 and a low of $53.40. At a current price of $54.37, the stock is +1.8% higher than the low and still -0.6% under the high.
Trading activity shows a volume of 18.04M, compared to an average daily volume of 16.85M.
Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $63.33 and a low of $42.52.
Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $63.33 and a low of $42.52.
BMY News
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge...
In recent trading, shares of Bristol Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $71.50, changing hands for $...
BofA Securities upgraded Bristol Myers Squibb & Co. (NYSE:BMY) , citing near-term catalysts. “What we like about BMY is the valuation coupled with our forecast...
Analyst ratings
63%
of 30 ratingsMore BMY News
Here Are Monday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, GE Vernova, KLA Corp., Klaviyo, Las Vegas Sands, ServiceNow, and More Quick Rea...
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Low PE Investor m...
Here Are Friday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More Quick R...
William Blair analyst Matt Phipps has reiterated their neutral stance on BMY stock, giving a Hold rating yesterday. Claim 50% Off TipRanks Premium and Invest wi...
Bristol-Myers Squibb (BMY) has quietly pushed higher over the past month, even as its longer term returns remain underwhelming. That mix of recent momentum and...
